Literature DB >> 15525373

Microbial Threat--The Copenhagen Recommendations initiative of the EU.

N Frimodt-Møller1.   

Abstract

The Microbial Threat was the name of an invitational EU conference held in Copenhagen in 1998, which for the first time made antibiotic resistance an official EU issue. The initiative resulted in a set of conclusions, which together with a summary of the conference was published as The Copenhagen Recommendations. This was soon followed by an EU Council Recommendation in 2001 exhorting the member states to follow and enact the recommendations from the Copenhagen meeting. Funding from EU research funds was later provided for projects monitoring resistance as well as antibiotic use, both of which have been lacking in most EU countries until now. The initiative is a good example of a major health issue being lifted by a concerted and official EU action.

Mesh:

Year:  2004        PMID: 15525373     DOI: 10.1111/j.1439-0450.2004.00786.x

Source DB:  PubMed          Journal:  J Vet Med B Infect Dis Vet Public Health        ISSN: 0931-1793


  3 in total

1.  Monitoring antimicrobial resistance trends in commensal Escherichia coli from livestock, the Netherlands, 1998 to 2016.

Authors:  Ayla Hesp; Kees Veldman; Jeanet van der Goot; Dik Mevius; Gerdien van Schaik
Journal:  Euro Surveill       Date:  2019-06

Review 2.  Danish integrated antimicrobial resistance monitoring and research program.

Authors:  Anette M Hammerum; Ole E Heuer; Hanne-Dorthe Emborg; Line Bagger-Skjøt; Vibeke F Jensen; Anne-Marie Rogues; Robert L Skov; Yvonne Agersø; Christian T Brandt; Anne Mette Seyfarth; Arno Muller; Karin Hovgaard; Justin Ajufo; Flemming Bager; Frank M Aarestrup; Niels Frimodt-Møller; Henrik C Wegener; Dominique L Monnet
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

3.  Antibiotic use on German pig farms - A longitudinal analysis for 2011, 2013 and 2014.

Authors:  Malin Hemme; Inga Ruddat; Maria Hartmann; Nicole Werner; Lisa van Rennings; Annemarie Käsbohrer; Lothar Kreienbrock
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.